Schedule 13G ownership disclosure
VIRPAX PHARMACEUTICALS INC
Security class unavailable · CUSIP: 928251206
Event date: 2024-05-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 110,727
- Percent of class
- 4.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-24-046267
- Form type
- SC 13G
- Filer
- INTRACOASTAL CAPITAL, LLC
- CIK
- CIK 1646799
- Filed
- May 23, 2024
- Reporting period
- May 14, 2024
- Description
- Schedule 13G beneficial ownership